Dr. Manish Aggarwal, Senior Pulmonologist & Interventional Chest Specialist in Pitampura, Delhi, provides specialized care for Interstitial Lung Disease (ILD), pulmonary fibrosis, autoimmune-related lung disease, and progressive breathlessness disorders.
Interstitial Lung Disease refers to a group of conditions causing inflammation and scarring of the lungs, leading to cough, breathlessness, reduced oxygen levels, and gradual decline in lung function. Early diagnosis and timely treatment are extremely important to slow disease progression and improve quality of life.
The clinic offers comprehensive evaluation for ILD patients including HRCT chest interpretation, pulmonary function testing (PFT), oxygen assessment, autoimmune workup coordination, bronchoscopy support, and multidisciplinary management planning. Patients with persistent dry cough, unexplained breathlessness, abnormal CT scans, connective tissue disease, or suspected pulmonary fibrosis receive evidence-based personalized care.
Special expertise is available for rheumatoid arthritis-associated ILD, systemic sclerosis-related ILD, hypersensitivity pneumonitis, post-COVID lung fibrosis, smoking-related ILD, sarcoidosis, and idiopathic pulmonary fibrosis (IPF).
The clinic focuses on early diagnosis, individualized treatment planning, patient counselling, pulmonary rehabilitation guidance, and long-term respiratory care for complex interstitial lung diseases.
Book consultation for expert ILD, pulmonary fibrosis, and advanced respiratory care in Delhi.
Find answers to common questions about lung cancer screening, lung nodule evaluation, bronchoscopy, biopsy procedures, hemoptysis assessment, smoking-related lung disease, and advanced respiratory care at Delhi Lung & Bronchoscopy Center.
Interstitial Lung Disease (ILD) refers to a group of lung disorders that cause inflammation and scarring of the lung tissue. Over time, this scarring can make it difficult for the lungs to transfer oxygen into the bloodstream, leading to breathlessness, cough, and reduced lung function.
Pulmonary fibrosis is a condition in which lung tissue becomes scarred and stiff. This scarring can progressively reduce lung function, making breathing more difficult. Early diagnosis and appropriate treatment can help slow disease progression and improve quality of life.
Common symptoms include persistent dry cough, progressive breathlessness, fatigue, reduced exercise tolerance, low oxygen levels, and difficulty performing daily activities. Symptoms often develop gradually and may worsen over time if left untreated.
Diagnosis typically involves a detailed clinical assessment, HRCT chest imaging, Pulmonary Function Testing (PFT), oxygen evaluation, laboratory investigations, and, in selected cases, bronchoscopy or additional specialized tests. A multidisciplinary approach is often used for accurate diagnosis.
HRCT (High-Resolution Computed Tomography) is one of the most important investigations for ILD. It provides detailed images of the lungs and helps identify patterns of inflammation, fibrosis, and other abnormalities that assist in determining the specific type of interstitial lung disease.
Yes. Autoimmune conditions such as rheumatoid arthritis, systemic sclerosis, lupus, and other connective tissue diseases can involve the lungs and cause interstitial lung disease. Early detection and coordinated care are important to prevent disease progression.
Idiopathic Pulmonary Fibrosis (IPF) is a chronic and progressive form of pulmonary fibrosis in which the exact cause is unknown. It leads to increasing lung scarring over time and requires specialized evaluation, monitoring, and treatment.
Some patients may develop residual lung scarring or fibrosis following severe COVID-19 infection. Persistent breathlessness, reduced oxygen levels, or abnormal CT findings after recovery may require evaluation by a pulmonologist.
Hypersensitivity pneumonitis is an inflammatory lung condition caused by repeated exposure to certain environmental allergens such as bird proteins, mold, dust, or agricultural particles. Early diagnosis and avoidance of triggers are important for preventing permanent lung damage.
Not all patients require oxygen therapy. Oxygen is recommended when blood oxygen levels fall below normal or when patients experience significant oxygen desaturation during activity. Oxygen requirements are determined through proper clinical assessment and testing.
Pulmonary Function Testing helps assess lung capacity, measure disease severity, monitor progression, and evaluate response to treatment. Regular PFT monitoring is an important part of long-term ILD and pulmonary fibrosis care.
While many forms of pulmonary fibrosis cannot be completely reversed, early diagnosis, appropriate treatment, pulmonary rehabilitation, lifestyle modifications, and regular monitoring can help slow disease progression, reduce symptoms, and improve quality of life.
We are available to answer queries, schedule urgent EBUS sessions or arrange Sleep diagnostic devices.